AGC supports employer right to maintain safe, drug-free workplaces.

On April 1, the US House of Representatives will consider and likely pass the Marijuana Opportunity Reinvestment and Expungement (MORE) Act (H.R. 3617), which would remove marijuana from the federally controlled substances list, thereby allowing individual states to determine whether or not to legalize it.

AGC has led efforts calling for Congress to consider the outcomes on workplace safety and the need for developing an evidence-based standard for detecting marijuana impairment before passing such legislation.

The MORE Act could have wide-reaching implications with every workplace needing to revise their drug testing programs, because employers could have difficulty testing for marijuana or taking employment action against anyone testing positive for the use of marijuana. The bill will likely undergo changes before it would be considered by the Senate or become law. As such, AGC will continue to call for a broad safety-sensitive position carve out, allowing employers to continue fair and reasonable drug testing programs.